For laboratory research use only. Not for human or veterinary use.

BPC-157 + TB-500 QuickPen

What the BPC-157 + TB-500 QuickPen is

The BPC-157 + TB-500 QuickPen combines two research peptides in a single pre-filled pen: BPC-157, a 15-amino-acid fragment of a gastric protein, and TB-500, a synthetic peptide based on thymosin beta-4. They are often used together in tissue-repair models.

The same blend is available as a lyophilised vial (10 mg of each peptide) on the BPC-157 + TB-500 page. Celvive supplies it for laboratory research only.

Where BPC-157 + TB-500 has been studied

Each peptide has its own literature, and a smaller number of studies look at them together. The main themes are:

  • Tendon and ligament models: including a 2026 rat Achilles tendon study of both peptides.
  • Cell migration: fibroblast outgrowth for BPC-157 and actin regulation for TB-500.
  • Angiogenesis and wound repair: studied separately for each compound.

Limits of the evidence

Combination data are limited and preclinical. Neither peptide is approved as a medicine by the EMA or the FDA.

Working with the QuickPen in the lab

The QuickPen is a pre-filled presentation; its fill volume and concentration are not yet published on the product label, so confirm the batch details on your certificate before planning an experiment. Storage and stability guidance is in the FAQ, and a batch certificate can be requested on the certificates of analysis page.

The peptides are also available as single QuickPens, BPC-157 and TB-500, or as vials of BPC-157 and TB-500. Browse Recovery and tissue research.

BPC-157 + TB-500 QuickPen research FAQ

How does the QuickPen differ from the blend vial?

The vial holds 10 mg of each peptide as lyophilised powder for reconstitution. The QuickPen is pre-filled; check the label and your batch certificate for its amount per pen and concentration.

Why use a blend rather than two pens?

A blend gives a fixed ratio in one presentation. Separate pens let the two peptides be used independently.

Is it an approved medicine?

No. It is a research reagent for laboratory use only.

Selected literature

PubMed records selected for relevance to the compound. They describe published research, not outcomes or uses.